InflaRx inflarx.com


Public lists: Pharma Startups (4731)

InflaRx is a biopharmaceutical company developing new therapeutics in the terminal complement space. InflaRx focuses on applying its proprietary anti-C5a technology to discover and develop specific inhibitors of C5a, an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. The company is also developing additional molecules targeting chronic and inflammation-related diseases.

InflaRx is a biopharmaceutical company developing new therapeutics in the terminal complement space. InflaRx focuses on applying its proprietary anti-C5a technology to discover and develop specific inhibitors of C5a, an inflammatory mediator involved...Show all

Company (IPO / Went public)

Phone: +49 (0)3641 508 180

Fax:

Winzerlaer Str. 2

Jena, D-07745
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
InflaRx $189M Nov 8, 2017
Intarcia Therapeutics $1513.7M Apr 3, 2017
ARYX Therapeutics $132M Nov 5, 2008
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related InflaRx Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-c5a binding moieties with high blocking activity Jun 03, 2015 Oct 04, 2016 Patent
Anti-c5a binding moieties with high blocking activity Jun 27, 2014 Jul 07, 2015 Patent
Anti-c5a binding antibodies with high block activity Nov 26, 2010 Aug 12, 2014 Patent
Anti-c5a binding moieties with high blocking activity Sep 16, 2016 Application
Inhibitors of c5a for the treatment of viral pneumonia Mar 20, 2015 Application